4.5 Article

Modify or die? - RNA modification defects in metazoans

Journal

RNA BIOLOGY
Volume 11, Issue 12, Pages 1555-1567

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/15476286.2014.992279

Keywords

cancer; metabolism; methylation; mitochondria; mRNA; neuropathy; RNA modification; translation; tRNA; rRNA

Funding

  1. Max Planck Society
  2. North Rhine-Westphalian Ministry for Innovation, Science and Research [314-400 010 09]
  3. European Research Council [ERC-2012-StG 310489-tRNAmodi]

Ask authors/readers for more resources

Chemical RNA modifications are present in all kingdoms of life and many of these post-transcriptional modifications are conserved throughout evolution. However, most of the research has been performed on single cell organisms, whereas little is known about how RNA modifications contribute to the development of metazoans. In recent years, the identification of RNA modification genes in genome wide association studies (GWAS) has sparked new interest in previously neglected genes. In this review, we summarize recent findings that connect RNA modification defects and phenotypes in higher eukaryotes. Furthermore, we discuss the implications of aberrant tRNA modification in various human diseases including metabolic defects, mitochondrial dysfunctions, neurological disorders, and cancer. As the molecular mechanisms of these diseases are being elucidated, we will gain first insights into the functions of RNA modifications in higher eukaryotes and finally understand their roles during development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available